Adenovirus-mediated in vivo gene transfer rapidly protects ornithine transcarbamylase-deficient mice from an ammonium challenge

Pediatric Research

Volumn 41, Issue 4 I, 1997, Pages 527-534

  Ye, Xuehai ^a   Robinson, Michael B ^b,c   Pabin, Carol ^b   Quinn, Theresa ^c   Jawad, Abbas ^a   Wilson, James M ^a   Batshaw, Mark L ^b,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d Children's Seashore House   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMMONIA; ASPARTIC ACID; GLUTAMINE; ORNITHINE CARBAMOYLTRANSFERASE;

ADENOVIRUS; ADOLESCENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE TRANSFER; METABOLIC DISORDER; MOUSE; NITROGEN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VIRUS RECOMBINANT;

EID: 0030961455     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199704000-00012     Document Type: Article

References (33)

1. Brusilow SW, Horwich AL 1995 Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp 1187-1232
2. Batshaw ML 1994 Inborn errors of urea synthesis. Ann Neurol 35:133-141
3. Nagata N, Matsuda I, Matsuura T, Oyanagi K, Tada K, Narisawa K, Kitagawa T, Sakiyama T, Yamashita F, Yoshino M 1991 Retrospective survey of urea cycle disorders. Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies. Am J Med Genet 40:477-481
4. Finkelstein JE, Hauser ER, Leonard CO, Brusilow SW 1990 Late-onset ornithine transcarbamylase deficiency in male patients. J Pediatr 117:897-902
5. Am PH, Hauser ER, Thomas GH 1990 Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. N Engl J Med 322:1652-1655
6. Batshaw ML, Msall M, Trojak J, Beaudet AL 1986 Risk of serious illness in heterozygotes of ornithine transcarbamylase deficiency. J Pediatr 108:236-241
7. Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK, Cann HM, Kerr D, Mamunes P, Matalon R, Myerberg D, Schafer IA 1982 Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med 306:1387-1392
8. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED 1984 Neurologic outcome in children with inborn errors of urea synthesis: outcome of urea-cycle enzymopathies. N Engl J Med 310:1500-1505
9. Todo S, Starzl TE, Tzakis A, Benkov KJ, Kalousek F, Saheki T, Tanikawa K, Fenton WA 1992 Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 15:419-422
10. Tuchman M 1989 Persistent acitrullinemia after liver transplantation for carbamylphosphate synthetase deficiency. N Engl J Med 320:1498-1499
11. Largilliere C, Houssin D, Gottrand F, Mathey C, Checoury A, Alagille D, Farriaux J 1989 Liver transplantation for ornithine transcarbamylase deficiency in a girl. J Pediatr 115:415-417
12. Veres G, Gibbs RA, Scherer SE, Caskey CT 1987 The molecular basis of the sparse fur mouse mutation. Science 237:415-417
13. ash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing. Proc Natl Acad Sci USA 86:4142-4146
14. Batshaw ML, Yudkoff M, McLaughlin B, Gorry E, Anegawa NJ, Smith IA, Hyman SL, Robinson MB 1995 The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency. Gene Ther 2:743-749
15. Jaffe H 1992 Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature 1:372-378
16. Herz J, Gerard RD 1993 Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 90:2812-2816
17. Li Q, Kay M, Finegold M, Stratford-Perricaudet L, Woo S 1993 Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 4:403-409
18. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, Read M, Brinkhous KM, Woo SLC 1994 In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91:2353-2357
19. Engelhardt J, Ye X, Doranz B, Wilson J 1994 Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91:6196-6200
20. Yang Y, Ertl H, Wilson J 1994 MHC Class 1 restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1 deleted recombinant adenoviruses. Immunity 1:433-442
21. Yang Y, Nunes F, Berencsi K, Furth E, Gønczøl E, Wilson J 1994 Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91:4407-4411
22. Stratford-Perricaudet LD, Levrero M, Chasse JF, Perricaudet M, Briand P 1990 Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1:241-256
23. Morsy M, Zhao J, Ngo T, Warman A, O'Brien W, Graham F, Caskey C 1996 Patient selection may affect gene therapy success: dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes. J Clin Invest 97:826-832
24. ash mice and in OTC-dericient human hepatocytes with recombinant adenoviruses bearing the CAG promoter. Hum Gene Ther 7:821-830
25. Ye X, Robinson MB, Batshaw ML, Furth EE, Smith I, Wilson JM 1996 Prolonged metabolic correction in adult ornithine transcarbamylase deficient mice with adenoviral vectors. J Bio Chem 271:3639-3646
26. Ensinger MJ, Ginsberg HS 1972 Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus. J Virol 10:328-339
27. Logan J, Shenk T 1984 Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc Natl Acad Sci USA 81:3655-3659
28. Engelhardt J, Litzky L, Wilson J 1994 Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther 5:1217-1229
29. Robinson MB, Djali S, Buchhalter JR 1993 Inhibition of glutamate uptake with L-trans-pyrrolidine-2,4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures. J Neurochem 61:2099-2103
30. Lee JT, Nussbaum RL 1989 An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells. J Clin Invest 84:1762-1766
31. Stewart PM, Walser M 1980 Short term regulation of ureagenesis. J Biol Chem 255:5270-5280
32. Bachmann C 1974 Urea cycle. In: Nyhan WL (ed) Heritable Disorders of Amino Acid Metabolism: Patterns of Clinical Expression and Genetic Variation. John Wiley & Sons, New York, pp 361-386
33. Batshaw ML, Monahan PS 1987 Treatment of urea cycle disorders. Enzyme 38:242-250